682 related articles for article (PubMed ID: 19531750)
41. [Mixed cryoglobulins and autoimmunity in hepatitis C].
Tridon A; Abergel A; Kuder P; Henquell C; Malaure H; Dibet P; Ghrib J; Bommelaer G; Bétail G
Pathol Biol (Paris); 1997 Apr; 45(4):291-7. PubMed ID: 9296077
[TBL] [Abstract][Full Text] [Related]
42. Evolution of Cryoglobulinemia in Direct-Acting Antiviral-Treated Asian Hepatitis C Patients With Sustained Virological Responses: A 4-Year Prospective Cohort Study.
Chang ML; Cheng JS; Chuang YH; Pao LH; Wu TS; Chen SC; Chang MY; Chien RN
Front Immunol; 2022; 13():823160. PubMed ID: 35371039
[TBL] [Abstract][Full Text] [Related]
43. Fibronectin gene polymorphisms are associated with the development of B-cell lymphoma in type II mixed cryoglobulinemia.
Fabris M; Quartuccio L; Salvin S; Pozzato G; De Re V; Mazzaro C; Ferri C; Baldini C; De Vita S
Ann Rheum Dis; 2008 Jan; 67(1):80-3. PubMed ID: 17526550
[TBL] [Abstract][Full Text] [Related]
44. Clinical implications of the types of cryoglobulins determined by two-dimensional polyacrylamide gel electrophoresis.
Tissot JD; Pietrogrande M; Testoni L; Invernizzi F
Haematologica; 1998 Aug; 83(8):693-700. PubMed ID: 9793252
[TBL] [Abstract][Full Text] [Related]
45. Systemic autoimmune diseases in patients with hepatitis C virus infection: characterization of 1020 cases (The HISPAMEC Registry).
Ramos-Casals M; Muñoz S; Medina F; Jara LJ; Rosas J; Calvo-Alen J; Brito-Zerón P; Forns X; Sánchez-Tapias JM;
J Rheumatol; 2009 Jul; 36(7):1442-8. PubMed ID: 19369460
[TBL] [Abstract][Full Text] [Related]
46. [Hepatitis C Virus-Induced Cryoglobulinemic Vasculitis].
Minami Y; Kudo M
Brain Nerve; 2018 Feb; 70(2):133-137. PubMed ID: 29433114
[TBL] [Abstract][Full Text] [Related]
47. Management of hepatitis C virus-related mixed cryoglobulinemia.
Iannuzzella F; Vaglio A; Garini G
Am J Med; 2010 May; 123(5):400-8. PubMed ID: 20399313
[TBL] [Abstract][Full Text] [Related]
48. Serological profile of asymptomatic HCV positive patients with low level of cryoglobulins.
Basile U; Napodano C; Pocino K; Gulli F; Santini SA; Todi L; Marino M; Rapaccini GL
Biofactors; 2019 May; 45(3):318-325. PubMed ID: 30561820
[TBL] [Abstract][Full Text] [Related]
49. [Cryoglobulinemic nephritis associated with chronic HCV infection].
Mukhin NA; Kozlovskaia LV; Malyshko EIu; Gordovskaia NB; Varshavskiĭ VA; Ignatova TM
Ter Arkh; 2000; 72(6):5-9. PubMed ID: 10900640
[No Abstract] [Full Text] [Related]
50. [Cryoglobulinemic peripheral neuropathy in hepatitis C virus infection: clinical and anatomical correlations of 22 cases].
Taieb G; Maisonobe T; Musset L; Cacoub P; Léger JM; Bouche P
Rev Neurol (Paris); 2010 May; 166(5):509-14. PubMed ID: 20338607
[TBL] [Abstract][Full Text] [Related]
51. Cryoglobulin-associated uptake of hepatitis C virus into human hepatocytes.
Hilgard P; Treichel U; Dries V; Dienes HP; Gerken G
Hepatogastroenterology; 2005; 52(65):1534-40. PubMed ID: 16201113
[TBL] [Abstract][Full Text] [Related]
52. [Cryoglobulinemia and chronic liver diseases].
Csepregi A; Nemesánszky E; Bély M
Z Gastroenterol; 1998 May; 36(5):391-401. PubMed ID: 9654707
[TBL] [Abstract][Full Text] [Related]
53. Prevalence of cryoglobulinemia in patients with chronic HCV infection.
Liakina V; Speiciene D; Irnius A; Naraskeviciene J; Barakauskiene A; Semuchiniene T
Med Sci Monit; 2002 Jan; 8(1):CR31-6. PubMed ID: 11782678
[TBL] [Abstract][Full Text] [Related]
54. Cryoglobulinemia in kidney transplant recipients.
Sens YA; Malafronte P; Souza JF; Bruno S; Gonzalez RB; Miorin LA; Jabur P; Forte WC
Transplant Proc; 2005 Dec; 37(10):4273-5. PubMed ID: 16387095
[TBL] [Abstract][Full Text] [Related]
55. Hepatitis C virus-associated mixed cryoglobulinemia. Clinical manifestations, histopathological changes, mechanisms of cryoprecipitation and options of treatment.
Schott P; Hartmann H; Ramadori G
Histol Histopathol; 2001 Oct; 16(4):1275-85. PubMed ID: 11642746
[TBL] [Abstract][Full Text] [Related]
56. Cryoglobulinemia.
Tedeschi A; Baratè C; Minola E; Morra E
Blood Rev; 2007 Jul; 21(4):183-200. PubMed ID: 17289231
[TBL] [Abstract][Full Text] [Related]
57. Rituximab for the treatment of type II mixed cryoglobulinemia.
Zaja F; De Vita S; Russo D; Michelutti A; Fanin R; Ferraccioli G; Baccarani M
Arthritis Rheum; 2002 Aug; 46(8):2252-4; author reply 2254-5. PubMed ID: 12209536
[No Abstract] [Full Text] [Related]
58. Disappearance of cryoglobulins and remission of symptoms in a patient with HCV-associated type II mixed cryoglobulinemia after HIV-1 infection.
Antinori S; Galimberti L; Rusconi S; Zehender G; Esposito R; Galli M
Clin Exp Rheumatol; 1995; 13 Suppl 13():S157-9. PubMed ID: 8730498
[TBL] [Abstract][Full Text] [Related]
59. Cerebral ischemic attack secondary to hepatitis C virus infection.
Cojocaru IM; Cojocaru M; Iacob SA; Burcin C
Rom J Intern Med; 2005; 43(3-4):255-60. PubMed ID: 16812984
[TBL] [Abstract][Full Text] [Related]
60. Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature.
Giuggioli D; Manfredi A; Colaci M; Manzini CU; Antonelli A; Ferri C
Autoimmun Rev; 2013 Sep; 12(11):1058-63. PubMed ID: 23806565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
